Data Availability
For all new products or new indications approved in both the European Union and the United States after January 1, 2014, the healthcare business of Merck KGaA, Darmstadt, Germany will share patient-level and study-level data after deidentification as well as redacted study protocols and clinical study reports from clinical trials in patients. These data will be shared with qualified scientific and medical researchers, upon the researcher's request, as necessary for conducting legitimate research. Such requests must be submitted in writing to the company's data sharing portal. More information can be found at 